Indies Pharma Jamaica Income Statement

Financials in millions JMD. Fiscal year is November - October.

Millions JMD. Fiscal year is Nov - Oct.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021
Revenue	1,126	1,159	1,055	937.28	846.83
Revenue Growth (YoY)	-2.82%	9.81%	12.61%	10.68%	10.56%
Cost of Revenue	457.76	465.82	417.41	323.44	329.81
Gross Profit	668.56	693.15	638.05	613.84	517.02
Selling, General & Admin	347.67	354.55	308.57	273.53	244.65
Other Operating Expenses	-8.04	-6.41	-4.23	1.15	1.5
Operating Expenses	405.3	410.01	367.82	332.13	299.61
Operating Income	263.27	283.15	270.24	281.71	217.41
Interest Expense	-62.71	-64.46	-66.78	-60.48	-68.96
Interest & Investment Income	1.74	1.6	1.46	0.95	4.84
Currency Exchange Gain (Loss)	0.72	8.78	1.86	-1.75	14.76
Other Non Operating Income (Expenses)	-2.66	-2.95	-3.29	-2.22	-2.59
EBT Excluding Unusual Items	200.37	226.12	203.48	218.21	165.47
Gain (Loss) on Sale of Assets	-	1.55	3.07	1.88	2.4
Pretax Income	200.37	251.77	217.63	220.79	167.87
Income Tax Expense	19.08	30.6	4.58	-	-
Net Income	181.29	221.18	213.06	220.79	167.87
Net Income to Common	181.29	221.18	213.06	220.79	167.87
Net Income Growth	-18.04%	3.81%	-3.50%	31.53%	-19.04%
Shares Outstanding (Basic)	1,333	1,333	1,333	1,333	1,333
Shares Outstanding (Diluted)	1,333	1,333	1,333	1,333	1,333
EPS (Basic)	0.14	0.17	0.16	0.17	0.13
EPS (Diluted)	0.14	0.17	0.16	0.17	0.13
EPS Growth	-18.04%	3.81%	-3.50%	31.53%	-19.04%
Free Cash Flow	320.3	241.13	265.45	288.85	325.76
Free Cash Flow Per Share	0.24	0.18	0.20	0.22	0.24
Dividend Per Share	0.135	0.110	0.110	0.113	0.110
Dividend Growth	22.73%	-	-2.66%	2.73%	-21.43%
Gross Margin	59.36%	59.81%	60.45%	65.49%	61.05%
Operating Margin	23.37%	24.43%	25.60%	30.06%	25.67%
Profit Margin	16.10%	19.08%	20.19%	23.56%	19.82%
Free Cash Flow Margin	28.44%	20.80%	25.15%	30.82%	38.47%
EBITDA	288.01	303.32	289.13	300.95	233.54
EBITDA Margin	25.57%	26.17%	27.39%	32.11%	27.58%
D&A For EBITDA	24.74	20.17	18.9	19.24	16.13
EBIT	263.27	283.15	270.24	281.71	217.41
EBIT Margin	23.37%	24.43%	25.60%	30.06%	25.67%
Effective Tax Rate	9.52%	12.15%	2.10%	-	-
Advertising Expenses	11.52	10.72	5.27	4.98	6.5

Updated Oct 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.